<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-128757</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sever calcinosis cutis successfully treated with a topical W/O-emulsion of sodium thiosulfpercentate 10</dc:title>
<dc:description xml:lang="en">Calcinosis cutis is a disease caused by accumulation and deposition of calcium salts in the tissue, which can result in serious injuries, whose therapeutic approach is not clearly established: it is restricted to symptomatic treatment or intravenous sodium thiosulfate in the most severe cases, but its administration carries some risks and is particularly difficult in pediatric patients. We report the case of a 6 year old children diagnosed of severe skin calcinosis secondary to treatment with intravenous calcium gluconate, for who it was prescribed a topical formulation of sodium thiosulfate 10%. In the pharmacy department of the hospital where the study was conducted, the topical formulation was prepared as aqueous/oil emulsion. The patient experienced a successfully, rapid and progressive recovery with the treatment prescribed (AU)</dc:description>
<dc:creator>Pérez-Moreno, M. A</dc:creator>
<dc:creator>Bernabeu-Wittel, J</dc:creator>
<dc:creator>Flores-Moreno, S</dc:creator>
<dc:creator>Álvarez del Vayo-Benito, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La calcinosis cutánea es una enfermedad producida por acumulación y depósito de sales de calcio en los tejidos, que puede dar lugar a importantes lesiones, y cuyo abordaje terapéutico no está claramente establecido: se restringe al tratamiento sintomático o tiosulfato sódico intravenoso en los casos más graves, pero su administración conlleva unos riesgos y se hace especialmente difícil en pacientes pediátricos. Presentamos el caso de un niño de 6 años de edad, diagnosticado de calcinosis cutánea grave secundaria a un tratamiento con gluconato cálcico intravenoso, al que se prescribió una fórmula magistral de tiosulfato sódico tópico al 10%. En el servicio de farmacia del hospital donde se desarrolló el estudio, se llevó a cabo la formulación del tratamiento en forma de emulsión acuosa/oleosa. El paciente experimentó una rápida y progresiva curación con la fórmula magistral prescrita (AU)</dc:description>
<dc:source>Acta Pediatr Esp;72(1): e9-e10, ene. 2014. ilus</dc:source>
<dc:identifier>ibc-128757</dc:identifier>
<dc:title xml:lang="es">Calcinosis cutánea grave tratada exitosamente con una fórmula magistral tópica W/O de tiosulfato sódico al 10 por ciento</dc:title>
<dc:subject>^d2148^s22044</dc:subject>
<dc:subject>^d2672^s22045</dc:subject>
<dc:subject>^d2148^s22011</dc:subject>
<dc:subject>^d2148^s22012</dc:subject>
<dc:subject>^d2672^s22066</dc:subject>
<dc:subject>^d2672^s22011</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d2148^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2672^s22048</dc:subject>
<dc:type>article</dc:type>
<dc:date>201401</dc:date>
</metadata>
</record>
</ibecs-document>
